Moranchel-García L

Language: Spanish
References: 12
Page: 686-693
PDF size: 216.39 Kb.

ABSTRACT

Objective: To present a descriptive analysis carried out at the Toxicological Center of the Angeles Lomas Hospital, Mexico.
Patients and Method: A descriptive study of patients treated at the Toxicological Center of the Angeles Lomas Hospital, Mexico, from 2012 to 2019. Patients with intoxication secondary to a suicide attempt were identified. A database was analyzed to validate that they met the established inclusion criteria and the information was collected in a database designed for this purpose.
Results: Two-hundred twenty-nine patients with suicide attempt were treated, which represented 20% of the total of intoxicated patients treated in the study period. The xenobiotics involved in each intake were distributed as follows: cyclic antidepressants: 10, benzodiazepines: 101, serotonin reuptake inhibitors: 2, antipsychotics: 16, paracetamol: 13, metals: 3, drugs of abuse: 51, phosphides: 1, antibiotics/antivirals: 58, opioids: 9, plants and herbal preparations: 6, others (anticoagulants, hypoglycemic agents, anticonvulsants): 159, gas (butane): 1.
Conclusions: The approach to the suicidal patient involves a multidisciplinary team, which must be made up of toxicologists, emergency physicians, psychiatrists and psychotherapists, as well as other specialists who are required depending on the xenobiotic involved and the patient’s clinical situation (internists, intensivists, gastroenterologists, neurologists, cardiologists and surgeons).

REFERENCES

1. Borges G, Rosovsky H, Gómez C, Gutiérrez R. Epidemiología del suicidio en México. Salud Publica Mex 1996; 38: 197-206.

2. Levi F, La Vecchia C, Lucchini F, Negri E, Saxena S, Maulik PK et al. Trends in mortality from suicide, 1965-99. Acta Psychiatr Scand 2003; 108: 341-349. doi: 10.1034/j.1600- 0447.2003.00147.x.

3. Borges G, Wilcox HC, Medina-Mora ME, Zambrano J, Blanco J, Walters E. Lifetime and 12 month prevalence, psychiatric factors and service utilization. Salud Mental 2005; 28: 40-47.

4. Nock MK, Borges G, Bromet EJ, Alonso J, Angermeyer M, Beautrais A, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry 2008; 192: 98-105. doi: 10.1192/bjp.bp.107.040113.

5. Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J, Fleiz C, et al. Prevalence of mental disorders and use of services: Results from the Mexican Nacional Survey of Psychiatric Epidemiology. Salud Mental 2003; 26: 1-16.

6. Kessler RC, Ustun TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004; 13: 93-121.

7. Benjet C, Borges G, Medina-Mora ME, Zambrano J, Aguilar- Gaxiola S. Youth mental health in a populous city of the developing world: results from the Mexican Adolescent Mental Health Survey. J Child Psychol Psychiatry 2009; 50: 386-395. doi: 10.1111/j.1469-7610.2008.01962.x.

8. World Health Organization. Suicide Prevention and special programmes - Country reports and charts available. Disponible en: http://www.who.int/mental_health/prevention/ suicide/country_reports/en/index.html.

9. Mann JJ, Apter A, Bertolote J, Beautrais A, Currier D, Haas A, et al. Suicide prevention strategies: a systematic review. JAMA 2005; 294: 2064-2074. doi: 10.1001/ jama.294.16.2064.

10. Miller M, Borges G. Firearms and suicide in Mexico: intimation of mortality. JOVENes 2009; 32: 90-107.

11. Nock MK, Borges G, Bromet EJ, Cha CB, Kessler RC, Lee S. Suicide and suicidal behavior. Epidemiol Rev 2008; 30: 133-154. doi: 10.1093/epirev/mxn002.

12. Swift B, West K. Death certification: an audit of practice entering the 21st century. J Clin Pathol 2002; 55: 275-279. doi: 10.1136/jcp.55.4.275.